It is a key task for cancer research to search novel prognostic marker, improve early diagnostic rate, and new target of molecular targeted therapy of gastric cancer.
因此提高胃癌的早期诊断率、寻找新的治疗靶点及预后指标，是当前肿瘤研究的重要课题。
KRAS mutation frequency in tumor tissue, can be predicted non-small cell lung cancer molecular targeted therapy efficacy and prognosis, and molecular inhibitors of RAS genes is still in its infancy.
KRAS基因突变在恶性肿瘤组织中频发，可预测非小细胞肺癌分子靶向治疗的疗效和预后，针对RAS基因的分子抑制剂研究仍处于初级阶段。
The systemic therapy of non-small cell lung cancer (NSCLC) is moving away from the "one-size fits all" empiric chemotherapy to targeted therapy of specific molecular alternations.
非小细胞肺癌的系统治疗已经由“一刀切”的经典化疗转变为针对特异分子改变的靶向治疗。
The molecular targeted therapy for esophageal cancer, still in its infancy, is also an important area of the study in future esophageal cancer treatment.
而对于食管癌的分子靶向治疗，目前尚处于萌芽阶段，也是食管癌治疗研究的重点，并具有广阔的前景。
The molecular targeted therapy for esophageal cancer, still in its infancy, is also an important area of the study in future esophageal cancer treatment.
而对于食管癌的分子靶向治疗，目前尚处于萌芽阶段，也是食管癌治疗研究的重点，并具有广阔的前景。
应用推荐